Fibromyalgia Trial, Recruiting NCT06508385 Sponsor: Istanbul Medeniyet University Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT06508385
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You were diagnosed with Fibromyalgia at least 1 year ago, based on recognised medical guidelines (ACR criteria)
  • You are between 25 and 55 years old
  • You are female
  • You scored at least 24 on a standard memory and thinking assessment test (confirm with trial site)
  • You report a weekly pain level of at least 40 out of 100 on a standard pain scale
  • You have been taking a stable dose of certain approved Fibromyalgia medications for at least 6 months — these include medicines such as duloxetine, milnacipran, pregabalin, or gabapentin-type drugs

Who may not be able to join:

  • You have been diagnosed with inflammatory joint diseases, cancer, neurological conditions, connective tissue diseases, severe anaemia, or uncontrolled hormonal/gland disorders
  • Your Body Mass Index (BMI) is 30 or above (a measure of body weight relative to height)
  • You are currently pregnant
  • You are unable to understand, read, or speak Turkish
  • You have significant difficulties with hearing or vision
  • You have any metal implants or electronic devices in your body (such as a pacemaker) that would be unsafe during an MRI brain scan
  • You have a diagnosis of a serious mental health condition, heart disease, lung disease, epilepsy, or any other condition that could prevent you from safely taking part in the study activities (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nilüfer Kablan, PhD, İstanbul Medeniyet Üniversitesi

Phone: 05067638556

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Medeniyet University
Registry
ClinicalTrials.gov
Start date
13 August 2024
Est. completion
15 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Functional Magnetic Resonance; Measurement of pain-pressure threshold

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov